L3VLUP
ProSign in

ZTS in the 13F filings

Zoetis Inc · CUSIP 98978V103

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 12 Nov 2024
Managers listing it
24
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 19 listed it in both
Shares listed
50,089,861
combined, among listed positions
Reported value
$9.8bn
combined, at the quarter end

Among the 94 comparable managers: 13 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ZTS in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

24 of 24 holders

ActionFiling
AllianceBernstein LP15,388,528$3.0bn1.01%Added+414,20814 Nov 2024 (the filing on sec.gov)
Capital World Investors6,683,979$1.3bn0.20%Trimmed-99,39813 Nov 2024 (the filing on sec.gov)
Polen Capital Management LLC6,366,653$1.2bn3.21%Trimmed-679,39810 Feb 2025 (the filing on sec.gov)
Fidelity (FMR LLC)4,344,239$849m0.05%Trimmed-231,9395 Nov 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc4,126,021$806m0.09%Trimmed-667,90414 Nov 2024 (the filing on sec.gov)
Wellington Management Group LLP3,899,288$762m0.13%Trimmed-5,541,59414 Nov 2024 (the filing on sec.gov)
Invesco Ltd2,394,216$468m0.09%Added+394,09012 Nov 2024 (the filing on sec.gov)
Neuberger Berman Group LLC2,002,618$391m0.31%Added+9,77314 Nov 2024 (the filing on sec.gov)
Janus Henderson Group Ltd1,771,060$346m0.18%Trimmed-22,76114 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP812,727$159m0.19%Trimmed-22,95714 Nov 2024 (the filing on sec.gov)
Holocene Advisors LP567,146$111m0.45%Newnew14 Nov 2024 (the filing on sec.gov)
Man Group PLC464,360$91m0.24%Added+13,01814 Nov 2024 (the filing on sec.gov)
Squarepoint Ops LLC315,403$62m0.10%Trimmed-437,45014 Nov 2024 (the filing on sec.gov)
AQR Capital Management LLC262,932$51m0.07%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Acadian Asset Management LLC186,245$36m0.11%Added+11,45712 Nov 2024 (the filing on sec.gov)
Walleye Capital LLC179,685$35m0.07%Added+75,96414 Nov 2024 (the filing on sec.gov)
Woodline Partners LP177,542$35m0.29%Newnew14 Nov 2024 (the filing on sec.gov)
Bridgewater Associates LP51,789$10m0.06%Trimmed-30,92613 Nov 2024 (the filing on sec.gov)
Winton Group Ltd31,599$6.2m0.43%Newnew12 Nov 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP25,859$5.1munder 0.1%Added+17,45214 Nov 2024 (the filing on sec.gov)
PDT Partners LLC17,061$3.3m0.30%Added+6,46114 Nov 2024 (the filing on sec.gov)
GAMCO Investors Inc13,710$2.7munder 0.1%Trimmed-92114 Nov 2024 (the filing on sec.gov)
Caxton Associates LLP5,501$1.1munder 0.1%Newnew14 Nov 2024 (the filing on sec.gov)
Dodge & Cox1,700$332kunder 0.1%Held013 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
24 in Q3 2024 to 23 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ZTS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201321$2.9bnn.a.n.a.
Q3 201321$2.8bnn.a.n.a.
Q4 201317$2.8bnn.a.n.a.
Q1 201418$2.8bnn.a.n.a.
Q2 201415$3.2bnn.a.n.a.
Q3 201415$3.9bnn.a.n.a.
Q4 201424$5.2bnn.a.n.a.
Q1 201528$5.0bnn.a.n.a.
Q2 201527$5.1bnn.a.n.a.
Q3 201529$4.7bnn.a.n.a.
Q4 201524$5.5bnn.a.n.a.
Q1 201622$4.7bnn.a.n.a.
Q2 201620$4.7bnn.a.n.a.
Q3 201616$4.5bnn.a.n.a.
Q4 201617$4.6bnn.a.n.a.
Q1 201720$4.1bnn.a.n.a.
Q2 201719$5.0bnn.a.n.a.
Q3 201722$5.0bnn.a.n.a.
Q4 201717$5.2bnn.a.n.a.
Q1 201821$5.2bnn.a.n.a.
Q2 201825$5.5bnn.a.n.a.
Q3 201827$6.3bnn.a.n.a.
Q4 201831$6.6bnn.a.n.a.
Q1 201927$8.4bnn.a.n.a.
Q2 201930$8.9bnn.a.n.a.
Q3 201927$9.9bnn.a.n.a.
Q4 201925$10.5bnn.a.n.a.
Q1 202027$9.4bnn.a.n.a.
Q2 202023$10.8bnn.a.n.a.
Q3 202027$13.3bnn.a.n.a.
Q4 202025$13.7bnn.a.n.a.
Q1 202130$13.9bnn.a.n.a.
Q2 202128$15.8bnn.a.n.a.
Q3 202129$16.6bnn.a.n.a.
Q4 202129$21.1bnn.a.n.a.
Q1 202236$17.0bnn.a.n.a.
Q2 202237$15.4bnn.a.n.a.
Q3 202237$12.9bnn.a.n.a.
Q4 202230$12.0bnn.a.n.a.
Q1 202324$13.3bnn.a.n.a.
Q2 202326$13.3bnn.a.n.a.
Q3 202323$13.2bnn.a.n.a.
Q4 202319$14.5bn712
Q1 202435$12.2bn2511
Q2 202424$10.1bn1218
Q3 202424$9.8bn1311
Q4 202427$7.7bn1513
Q1 202528$7.2bn1710
Q2 202526$6.0bn1512
Q3 202527$5.9bn207
Q4 202521$5.1bn2322
Q1 202621$4.4bn1326
Q2 202623$2.7bn2714

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ZTS and LLY →ZTS and JNJ →ZTS and VRTX →Choose a stock to compare with ZTS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ZTS, latest filings →Back to the 13F Explorer →